Artal Group S.A. - NEXIMMUNE INC ownership

NEXIMMUNE INC's ticker is NEXI and the CUSIP is 65344D109. A total of 43 filers reported holding NEXIMMUNE INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Artal Group S.A. ownership history of NEXIMMUNE INC
ValueSharesWeighting
Q4 2022$292
-100.0%
1,200,0000.0%0.02%
-42.9%
Q3 2022$666,000
-65.5%
1,200,0000.0%0.03%
-72.8%
Q2 2022$1,932,000
-61.8%
1,200,0000.0%0.10%
-51.4%
Q1 2022$5,052,000
-8.7%
1,200,0000.0%0.21%
+41.3%
Q4 2021$5,532,000
-69.6%
1,200,0000.0%0.15%
-63.1%
Q3 2021$18,168,000
-7.2%
1,200,0000.0%0.41%
+2.3%
Q2 2021$19,584,000
-14.5%
1,200,0000.0%0.40%
-2.0%
Q1 2021$22,896,0001,200,0000.40%
Other shareholders
NEXIMMUNE INC shareholders Q2 2021
NameSharesValueWeighting ↓
ALLEN OPERATIONS LLC 635,934$10,378,0001.78%
Slate Path Capital LP 925,000$15,096,0000.84%
BRIDGER MANAGEMENT, LLC 400,000$6,528,0000.61%
Artal Group S.A. 1,200,000$19,584,0000.40%
DSAM Partners (London) Ltd 89,500$1,461,0000.24%
SUVRETTA CAPITAL MANAGEMENT, LLC 365,762$5,969,0000.09%
TimesSquare Capital Management, LLC 482,100$7,868,0000.06%
Johns Hopkins University 26,919$439,0000.05%
683 Capital Management, LLC 60,000$979,0000.03%
ADAGE CAPITAL PARTNERS GP, L.L.C. 704,371$11,495,0000.02%
View complete list of NEXIMMUNE INC shareholders